Response of chronic refractory psoriasis vulgaris with urticaria to combined secukinumab and omalizumab: A case report and review of the literature

J Cosmet Dermatol. 2023 Apr;22(4):1416-1418. doi: 10.1111/jocd.15551. Epub 2022 Dec 27.

Ayman Abdelmaksoud^{1

2}, Selami Aykut Temiz³, Munise Daye³, Sibel Yavuz³, Uwe Wollina⁴, Torello Lotti^{5

6}, Recep Dursun³

¹ Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
² Department of Dermatology, University of Studies Guglielmo Marconi, Rome, Italy.
³ Department of Dermatology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.
⁴ Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany.
⁵ University of Rome G. Marconi, Rome, Italy.
⁶ Department of Dermatology and Communicable Diseases, First Medical State Moscow University I. M. Sechenev, Moscow, Russia.

No abstract available

Keywords: chronic spontaneous urticaria; omalizumab; psoriasis; secukinumab.

Publication types